Skip to main content
. 2023 Mar 14;28(6):2622. doi: 10.3390/molecules28062622

Figure 2.

Figure 2

Metabolic pathways and known receptors of ECBs. Abbreviations: 12-HAEA—12-hydroxy-N-arachidoylethanolamine; 12-HETE-G—12-hydroxy eicosatetraenoylglycerol; 2-AG—2-arachidonoylglycerol; 5,6-EET-EA—5,6-epoxyeicosatrienoyl ethanolamide; AA—arachidonic acid; ABHD4—αβ-hydrolase domain 4 protein; AEA—N-arachidonoylethanolamine; CB1/2—cannabinoid receptor 1/2; COX-2—cyclooxygenase-2; CYP450—cytochrome P450; DAG—diacylglycerol; DAGL—diacylglycerol lipase; EtNH2—ethanolamine; FAAH—fatty acid amide hydrolase; GPR—G protein-coupled receptor; LOX—lipoxygenase; Lyso-NArPE—lyso-N-arachidonoyl phosphatidylethanolamine; Lyso-PLD—lysophospholipase D; MAGL—monoacylglycerol lipase; NAPE-PLD—N-acylphosphatidylethanolamines-specific phospholipase D; NArPE—N-arachidonoyl phosphatidylethanolamine; p-AEA—phospho-N-arachidonoylethanolamine; PGE2-G—prostaglandin E2 glycerol; PLA2—phospholipase A2; PLC—phospholipase C; PPARα/γ/δ—peroxisome proliferator activated receptor α/γ/δ; TRPV1—transient receptor potential vanilloid type-1.